hoth therapeutics inc shares fell more than 15 to 161 on wednesday and hit an alltime low after the biopharmaceutical company unveiled plans for a reverse merger with privately held algorithm sciences inc new yorkbased hoth said the allstock deal would leave its shareholders owning 14 of the combined company while